Insmed Incorporated (INSM) Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012  
11/8/2012 9:47:14 AM

MONMOUTH JUNCTION, N.J., Nov. 7, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company dedicated to the development of innovative inhaled pharmaceuticals for the treatment of serious lung infections, today reported results for the third quarter and nine-months ended September 30, 2012.